Compare · BTI vs OBIO
BTI vs OBIO
Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Orchestra BioMed Holdings Inc. (OBIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTI and OBIO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- BTI is the larger of the two at $128.51B, about 526.0x OBIO ($244.3M).
- Over the past year, BTI is up 24.3% and OBIO is up 30.5% - OBIO leads by 6.3 points.
- Both names hit the wire about 7 times in the past 4 weeks.
- BTI has more recent analyst coverage (14 ratings vs 9 for OBIO).
PerformanceBTI+24.28%OBIO+30.55%
2025-06-23+0.00%2026-06-23
- Company
- British American Tobacco Industries p.l.c.
- Orchestra BioMed Holdings Inc.
- Price
- $60.60+2.85%
- $4.06+0.00%
- Market cap
- $128.51B
- $244.3M
- 1M return
- -7.80%
- -1.10%
- 1Y return
- +24.28%
- +30.55%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- 2020
- News (4w)
- 7
- 7
- Recent ratings
- 14
- 9
BTI
British American Tobacco Industries p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
Latest BTI
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 11-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- Large owner Bt De Investments Inc. converted options into 95,281,277 shares and was granted 14,662,765 shares (SEC Form 4)
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
- SEC Form 6-K filed by British American Tobacco Industries p.l.c.
Latest OBIO
- Sidoti Events, LLC's June Small-Cap Virtual Conference
- Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 36,352 shares, decreasing direct ownership by 6% to 593,065 units (SEC Form 4) to satisfy tax liability
- Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.31% to 1,060,746 units (SEC Form 4) (tax withholding)
- Officer Hochman David P bought $19,150 worth of shares (5,000 units at $3.83), increasing direct ownership by 0.47% to 1,064,029 units (SEC Form 4)
- Officer Sherman Darren sold $58,050 worth of shares (15,000 units at $3.87) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,184,327 units (SEC Form 4)
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SEC Form 144 filed by Orchestra BioMed Holdings Inc.
- Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,076 shares, decreasing direct ownership by 0.49% to 629,417 units (SEC Form 4) (for tax liability)
- Officer Sherman Darren covered exercise/tax liability with 4,925 shares, decreasing direct ownership by 0.41% to 1,199,327 units (SEC Form 4) to satisfy tax liability
- Director Aryeh Jason bought $2,494 worth of shares (665 units at $3.75), increasing direct ownership by 0.57% to 118,118 units (SEC Form 4)